Contents

Current Cancer Drug Targets, Volume 9 - Number 6

Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma

, 9(6): 705 - 716

Debmalya Barh, Anil Kumar, Suvro Chatterjee and Triantafillos Liloglou


DOI: 10.2174/156800909789271549




Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?

, 9(6): 717 - 728

C. Constantinou, K. A. Papas and A. I. Constantinou


DOI: 10.2174/156800909789271512




The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma

, 9(6): 729 - 737

S. Fulda


DOI: 10.2174/156800909789271521




Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

, 9(6): 738 - 747

H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow and K. C. Soo


DOI: 10.2174/156800909789271530




Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

, 9(6): 748 - 760

J. van der Veeken, S. Oliveira, R. M. Schiffelers, G. Storm, P.M.P. van Bergen en Henegouwen and R. C. Roovers


DOI: 10.2174/156800909789271495




Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia

, 9(6): 761 - 776

H. Reikvam, E. Ersvær and O. Bruserud


DOI: 10.2174/156800909789271486




Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)

, 9(6): 777 - 788

J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz and Y. Jounaidi


DOI: 10.2174/156800909789271503




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science